skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters

Results 1 - 20 of 36  for All Library Resources

Results 1 2 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Infliximab for the treatment of plaque psoriasis
Material Type:
Article
Add to My Research

Infliximab for the treatment of plaque psoriasis

Biologics, 2008-03, Vol.2 (1), p.115-124 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Dove Medical Press Limited. All rights reserved ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S2116 ;PMID: 19707434

Full text available

2
Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase
Material Type:
Article
Add to My Research

Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase

Biologics, 2010-01, Vol.4, p.315-323 [Peer Reviewed Journal]

2010. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2010 Mughal and Schrieber, publisher and licensee Dove Medical Press Ltd. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/btt.s5775 ;PMID: 21209726

Full text available

3
Multikinase inhibitors use in differentiated thyroid carcinoma
Material Type:
Article
Add to My Research

Multikinase inhibitors use in differentiated thyroid carcinoma

Biologics, 2014-01, Vol.8 (default), p.281-291 [Peer Reviewed Journal]

2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Jasim et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S57619 ;PMID: 25506209

Full text available

4
Emerging hematological targets and therapy for cardiovascular disease : from bench to bedside
Material Type:
Article
Add to My Research

Emerging hematological targets and therapy for cardiovascular disease : from bench to bedside

Biologics, 2008-09, Vol.2 (3), p.397-407 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Villegas et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S2911 ;PMID: 19707371

Full text available

5
Biological drugs targeting the immune response in the therapy of psoriasis
Material Type:
Article
Add to My Research

Biological drugs targeting the immune response in the therapy of psoriasis

Biologics, 2008-12, Vol.2 (4), p.687-697 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Pastore et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S2763 ;PMID: 19707449

Full text available

6
Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis
Material Type:
Article
Add to My Research

Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis

Biologics, 2014-01, Vol.8 (default), p.169-182 [Peer Reviewed Journal]

COPYRIGHT 2014 Dove Medical Press Limited ;2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Kivelevitch et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S41481 ;PMID: 24790410

Full text available

7
Optimizing therapeutics in the management of patients with multiple sclerosis : a review of drug efficacy, dosing, and mechanisms of action
Material Type:
Article
Add to My Research

Optimizing therapeutics in the management of patients with multiple sclerosis : a review of drug efficacy, dosing, and mechanisms of action

Biologics, 2013-01, Vol.7 (default), p.247-258 [Peer Reviewed Journal]

COPYRIGHT 2013 Dove Medical Press Limited ;2013. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Damal et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2013 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S53007 ;PMID: 24324326

Full text available

8
Bevacizumab in the treatment of HER2-negative breast cancer
Material Type:
Article
Add to My Research

Bevacizumab in the treatment of HER2-negative breast cancer

Biologics, 2008-01, Vol.2 (4), p.813-821 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Dove Medical Press Limited. All rights reserved ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/btt.s3515 ;PMID: 19707460

Full text available

9
Current neoadjuvant treatment options for HER2 positive breast cancer
Material Type:
Article
Add to My Research

Current neoadjuvant treatment options for HER2 positive breast cancer

Biologics, 2011-01, Vol.5 (default), p.87-94 [Peer Reviewed Journal]

2011. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2011 Abdel-Razeq and Marei, publisher and licensee Dove Medical Press Ltd. 2011 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S22917 ;PMID: 21847344

Full text available

10
Resistant mutations in CML and Ph+ALL - role of ponatinib
Material Type:
Article
Add to My Research

Resistant mutations in CML and Ph+ALL - role of ponatinib

Biologics, 2014-01, Vol.8 (default), p.243-253 [Peer Reviewed Journal]

2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Miller et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S50734 ;PMID: 25349473

Full text available

11
Drug focus : adalimumab in the treatment of moderate to severe psoriasis
Material Type:
Article
Add to My Research

Drug focus : adalimumab in the treatment of moderate to severe psoriasis

Biologics, 2007-06, Vol.1 (2), p.93-103 [Peer Reviewed Journal]

Copyright Taylor & Francis Ltd. 2007 ;2007 Dove Medical Press Limited. All rights reserved ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;PMID: 19707319

Full text available

12
Adalimumab for the treatment of Crohn's disease
Material Type:
Article
Add to My Research

Adalimumab for the treatment of Crohn's disease

Biologics, 2008-01, Vol.2 (4), p.763-777 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Dove Medical Press Limited. All rights reserved ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S3292 ;PMID: 19707457

Full text available

13
HER2 breast cancer therapies : a review
Material Type:
Article
Add to My Research

HER2 breast cancer therapies : a review

Biologics, 2009-01, Vol.3 (default), p.289-301 [Peer Reviewed Journal]

2009. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2009 Murphy and Modi, publisher and licensee Dove Medical Press Ltd ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S3479 ;PMID: 19707416

Full text available

14
Effect of mild aerobic training on the myocardium of mice with chronic Chagas disease
Material Type:
Article
Add to My Research

Effect of mild aerobic training on the myocardium of mice with chronic Chagas disease

Biologics, 2015-01, Vol.9 (default), p.87-92 [Peer Reviewed Journal]

COPYRIGHT 2015 Dove Medical Press Limited ;2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Preto et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S85283 ;PMID: 26445527

Full text available

15
Epoetin zeta in the management of anemia associated with chronic kidney disease, differential pharmacology and clinical utility
Material Type:
Article
Add to My Research

Epoetin zeta in the management of anemia associated with chronic kidney disease, differential pharmacology and clinical utility

Biologics, 2014-01, Vol.8 (default), p.155-167 [Peer Reviewed Journal]

COPYRIGHT 2014 Dove Medical Press Limited ;2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Davis-Ajami et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S27578 ;PMID: 24790409

Full text available

16
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
Material Type:
Article
Add to My Research

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants

Biologics, 2008-09, Vol.2 (3), p.433-439 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Dove Medical Press Limited. All rights reserved ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/btt.s3104 ;PMID: 19707374

Full text available

17
Safety of biologics in rheumatoid arthritis : data from randomized controlled trials and registries
Material Type:
Article
Add to My Research

Safety of biologics in rheumatoid arthritis : data from randomized controlled trials and registries

Biologics, 2015-01, Vol.9 (default), p.1-6 [Peer Reviewed Journal]

COPYRIGHT 2015 Dove Medical Press Limited ;2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Codreanu and Damjanov. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S68949 ;PMID: 25670881

Full text available

18
Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes
Material Type:
Article
Add to My Research

Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes

Biologics, 2010-09, Vol.4 (default), p.245-261, Article 245 [Peer Reviewed Journal]

2010. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2010 Kanduc, publisher and licensee Dove Medical Press Ltd. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S12097 ;PMID: 20859452

Full text available

19
Clinical use of crizotinib for the treatment of non-small cell lung cancer
Material Type:
Article
Add to My Research

Clinical use of crizotinib for the treatment of non-small cell lung cancer

Biologics, 2013-01, Vol.7 (default), p.91-101 [Peer Reviewed Journal]

2013. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Roberts, publisher and licensee Dove Medical Press Ltd 2013 ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S29026 ;PMID: 23671386

Full text available

20
Pharmacoutilization of epoetins in naïve patients with hematological malignancies in an unselected Italian population under clinical practice setting : a comparative analysis between originator and biosimilars
Material Type:
Article
Add to My Research

Pharmacoutilization of epoetins in naïve patients with hematological malignancies in an unselected Italian population under clinical practice setting : a comparative analysis between originator and biosimilars

Biologics, 2016-12, Vol.10, p.157-165 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;2016 Perrone et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-5491 ;ISSN: 1177-5475 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S114625 ;PMID: 27942203

Full text available

Results 1 - 20 of 36  for All Library Resources

Results 1 2 next page

Searching Remote Databases, Please Wait